REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/13/2026
Back to search
Official data from USPTO
POLARYX THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
06/14/2026
Trademark type
Combined
Nice classes
42
Filing date
05/05/2016
Registration date
06/13/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/30/2022
Last transaction
06/14/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/15/2017
First use in commerce
03/15/2017
Drawing code
5
Owner type
03
Owner location
Carson City, NV, US
Examiner
COLLOPY, DIANE PATRICIA
Law office
P10
Current location
TMO LAW OFFICE 137
Mark description
The mark consists of the stylized word "Polaryx" where the letter "P" is in colors dark green, green and pastel green and the rest of the letters are in gray. The left lower arms of the letter "P" is elongated, and the top part of the letter "P" is extended over the top of the letters "Th" of the word "Therapeutics" in gray appears below the word "Polaryx".
Holders and representatives
Holders
POLARYX THERAPEUTICS, INC.
POLARYX THERAPEUTICS, INC
POLARYX THERAPEUTICS, INC
Representatives
Hun Joon Kim LEX IP MEISTERS, PLLC.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Researchdevelopmentengineeringtestingproduct evaluationinspection in the field of pharmaceutical preparations and products; Medical and scientific researchconducting clinical trials for others for pharmaceutical preparations used for the treatment of lysosomal storage disorders; Scientific researchconsultingadvice in the fields of pharmaceutical technologypharmaceutical research and developmentthe life sciences; Providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticalsthe life sciencesclinical trialsmedicinedisease classificationgenetic disorders and biotechnology
Publications
History of USPTO decisions and trademark events.
34 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/24/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/24/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/24/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/24/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/24/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/22/2026
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/30/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/30/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/30/2022
E815
TEAS SECTION 8 & 15 RECEIVED
06/15/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/13/2022
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
08/08/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/07/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
07/04/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/12/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/11/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/11/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/11/2017
IUAF
USE AMENDMENT FILED
04/18/2017
EISU
TEAS STATEMENT OF USE RECEIVED
04/18/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/13/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/18/2016
PUBO
PUBLISHED FOR OPPOSITION
10/18/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/28/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/31/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
08/23/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/23/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
08/23/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/23/2016
DOCK
ASSIGNED TO EXAMINER
08/20/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/10/2016
NWAP
NEW APPLICATION ENTERED
05/09/2016
Continuous trademark protection
Get notified about every new filing that threatens POLARYX THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.